Prognostic significance of pre-treatment albumin-bilirubin grade in metastatic urothelial carcinoma receiving pembrolizumab

20235 citationsJournal Article

Authors

Shimpei Yamashita · Wakayama Medical University

Takuma Wada · Wakayama Medical University

Ryusuke Deguchi · Wakayama Medical University

Nobuyuki Mashima · Kinan Hospital

Masatoshi Higuchi

Haruka Miyai · Kishiwada Tokushukai Hospital

Hiroyuki Koike · Wakayama Rosai Hospital

Abstract

High pre-treatment albumin-bilirubin grade could be a significant independent predictor of poor prognosis in patients receiving pembrolizumab for advanced urothelial carcinoma.

Topics & Keywords

Bladder and Urothelial Cancer Treatments Urinary and Genital Oncology Studies Cancer Immunotherapy and Biomarkers

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Japanese Journal of Clinical Oncology

Volume 53, Issue 9, pp. 845-850

DOI: 10.1093/jjco/hyad069

Field-Weighted Citation Impact: 1.62